Am J Transplant, Volume 21, Suppl 3 Archives - Page 16 of 139 - ATC Abstracts

2021 American Transplant Congress
Evaluation of the Impact of Delayed Graft Function (dgf) on Kidney Allograft Outcomes
J. Leeds, B. Rawashdeh, M. Sestito, B. Sharma, J. Kamal, A. Kumar, A. AgarwalAA4VB, A. Doyle, S. Rao
University of Virginia, Charlottesville, VA
*Purpose: DGF is an important post-transplant complication that has early and long-term consequences on graft survival with increased relative risk of graft loss. DGF frequency…
2021 American Transplant Congress
Graft Loss in Adolescent and Young Adult Generation After Pediatric Kidney Transplantation: A Single Center Experience in Japan
Y. Aoki, Y. Hamasaki, M. Muramatsu, J. Hashimoto, M. Kubota, S. Shishido, K. Sakai
Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: Kidney transplant recipients of all ages may have difficulty adhering to a strict treatment plan, adolescents and young adults are at particularly high risk…
2021 American Transplant Congress
Pediatric Kidney Transplant Recipients Frequently Experience Utis Regardless of Esrd Etiology
E. Spiwak, C. Nailescu, A. Schwaderer
Indiana University Department of Pediatrics Division of Nephrology, Indianapolis, IN
*Purpose: Urinary tract infections (UTIs) remain the most common type of infectious complication experienced by renal allograft recipients. UTIs in transplant patients most commonly occur…
2021 American Transplant Congress
The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation
S. Lee¹, C. Yang², B. Chung²
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: De-novo anti-HLA-DQ donor-specific antibody (DSA) has been identified as a risk factor for late graft dysfunction and graft loss in kidney transplantation (KT). The…
2021 American Transplant Congress
HLA Allele Association with Recurrent Iga Nephropathy After Kidney Transplantation
O. Alzahabi, M. Merzkani, H. Murad, A. Java, R. Delos Santos, T. Alhamad, A. Malone
Transplant, Washington University, Saint Louis, MO
*Purpose: IgA nephropathy is one of the most common glomerulonephritis after kidney transplantation. The association of IgA nephropathy recurrence with recipient HLA typing is not…
2021 American Transplant Congress
Characterization of Chronic Renal Allograft Dysfunction at Single Cell Resolution
C. Kuscu¹, C. Kuscu², A. Shetty³, M. Talwar⁴, J. Eason², D. G. Maluf⁵, V. Mas⁶
¹Surgery, James D Eason Transplant Institute, UTHSC, Memphis, TN, ²Surgery, James D Eason Transplant Institute, Memphis, TN, ³Institute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, MD, ⁴Nephrology, James D Eason Transplant Institute, Memphis, TN, ⁵Surgery, Program in Transplantation - University of Maryland, Baltimore, MD, ⁶Surgery, Division of Surgical Science - University of Maryland, Baltimore, MD
*Purpose: Chronic allograft dysfunction (CAD) is one of the major complications after kidney transplantation. Hereby, we aim to assess the molecular and cellular mechanism of…
2021 American Transplant Congress
Predictive Factors of the Hepatic Artery Thrombosis in Liver Transplantation Through the Analysis of Donor Characteristics
M. M. Pascale¹, G. Moschetta², G. Bianco², F. Frongillo², E. Nure², F. Giovinazzo², S. Agnes²
¹General Surgery and Liver Transplant Unit, Fondazione, Roma, Italy, ²General Surgery and Liver Transplant Unit, Fondazione "Policlinico A. Gemelli" UCSC - Rome, Roma, Italy
*Purpose: Hepatic artery thrombosis (HAT) is one of the most severe complications after liver transplantation. It is treated as soon as possible to avoid irreversible…
2021 American Transplant Congress
Loneliness in Adults Awaiting Liver Transplantation at 7 U.S. Transplant Centers During the Covid-19 Pandemic
K. Berry¹, D. Kent¹, S. Seetharaman¹, R. Wong¹, Y. Mohamad¹, F. Yao¹, M. Duarte², B. Boyarsky³, R. Rahimi⁴, A. Duarte-Rojo⁵, M. Kappus⁶, M. Volk⁷, D. Ladner⁸, D. Segev³, M. McAdams-DeMarco³, E. Verna⁹, D. Ganger⁸, J. C. Lai¹
¹UCSF, San Francisco, CA, ²Johns Hopkins, Baltimore, CA, ³Johns Hopkins, Baltimore, MD, ⁴Baylor, Dallas, TX, ⁵Pittsburgh, Pittsburgh, PA, ⁶Duke, Durham, NC, ⁷Loma Linda, Loma Linda, CA, ⁸Northwestern, Chicago, IL, ⁹Columbia, New York, NY
*Purpose: Loneliness, defined by the National Academy of Medicine as “a subjective feeling of being isolated”, has recently emerged as a strong predictor of adverse…
2021 American Transplant Congress
Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective
K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida
Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY
*Purpose: Nonalcoholic steatohepatitis (NASH) and alcohol liver disease (ALD) are rapidly growing indications for liver transplantation (LT). The recent trends and outcomes in NASH and…
2021 American Transplant Congress
The Surgical Experience and Treatment Options for Hepatic Cystic Disease
M. Crowley¹, K. Robichaux², A. Kumar¹, J. Buggs³, J. Sokolich⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Hepatobiliary Surgery, Valley Presbyterian Hospital, San Fernando Valley, CA
*Purpose: Benign hepatic cysts may require surgical removal when symptomatic particularly in the setting of genetic disorders such as autosomal dominant polycystic kidney disease (ADPKD)…